Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Cindy Ippoliti"'
Autor:
Gail J. Roboz, Ellen K. Ritchie, Yulia Dault, Linda Lam, Danielle C. Marshall, Nicole M. Cruz, Hsiao-Ting C. Hsu, Duane C. Hassane, Paul J. Christos, Cindy Ippoliti, Joseph M. Scandura, Monica L. Guzman
Publikováno v:
Haematologica, Vol 103, Iss 8 (2018)
Acute myeloid leukemia carries a dismal prognosis in older patients. The objective of this study was to investigate the safety and efficacy of decitabine combined with the CXCR4 antagonist plerixafor in newly diagnosed older patients with acute myelo
Externí odkaz:
https://doaj.org/article/373fb383089440989a2d3b9efeec3de1
Autor:
Danielle C. Marshall, Cindy Ippoliti, Monica L. Guzman, Hsiao-Ting C. Hsu, Nicole M. Cruz, Linda Lam, Duane C. Hassane, Ellen K. Ritchie, Yulia Dault, Gail J. Roboz, Joseph M. Scandura, Paul J. Christos
Publikováno v:
Haematologica
Acute myeloid leukemia carries a dismal prognosis in older patients. The objective of this study was to investigate the safety and efficacy of decitabine combined with the CXCR4 antagonist plerixafor in newly diagnosed older patients with acute myelo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66718519458aec24976737d16f425f07
https://doi.org/10.3324/haematol.2017.183418
https://doi.org/10.3324/haematol.2017.183418
Autor:
Sebastian Mayer, Usama Gergis, Tsiporah B. Shore, Koen van Besien, Xi Kathy Zhou, Frank Cirrone, Hanhan Wang, Cindy Ippoliti
Publikováno v:
Leukemia & Lymphoma. 57:2555-2559
Human herpes virus type 6 can reactivate in patients after allogeneic stem cell transplantation and has been associated with serious sequelae such as delayed engraftment and an increased risk of developing acute graft-versus-host disease (GVHD). This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db90632cfd107b4de968929706c78d85
https://doi.org/10.3109/10428194.2016.1157873
https://doi.org/10.3109/10428194.2016.1157873
Autor:
Gail J. Roboz, Catherine B. Lagassa, Ellen K. Ritchie, Cindy Ippoliti, Sarah D. Rohan, Karen Carlson, Eric J. Feldman, Paul J. Christos, Joseph M. Scandura
Publikováno v:
Leukemia & Lymphoma. 54:2003-2007
Treatment options for older patients with acute myeloid leukemia (AML) and for patients with relapsed/refractory AML are limited, and outcomes are poor. Decitabine, a hypomethylating agent, is active in patients with myelodysplastic syndrome (MDS) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d63d3b12e62bee141cc4707dbe296c33
https://doi.org/10.3109/10428194.2012.762093
https://doi.org/10.3109/10428194.2012.762093
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 23(3)
The incidence of venous thromboembolism is greater among cancer patients than the general patient population, with recurrence rates also much higher in patients with cancer diagnoses. Patients with hematologic malignancies often experience prolonged
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97111260f7cc81e30e5a7d1f8e6c61ce
https://pubmed.ncbi.nlm.nih.gov/26854266
https://pubmed.ncbi.nlm.nih.gov/26854266
Autor:
Tania J. Curcio, Sebastian Mayer, Ewelina Morawa, Joseph M. Scandura, Cindy Ippoliti, Eric J. Feldman, Usama Gergis, Luis Villegas, Fabienne Brenet, Gail J. Roboz, J. Robi Bose, Michelle Moh, Ellen K. Ritchie
Publikováno v:
Blood. 118:1472-1480
We conducted an open-label phase 1 study exploring the feasibility, safety, and biologic activity of epigenetic priming with decitabine before standard induction chemotherapy in patients with less-than-favorable risk of acute myelogenous leukemia (AM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d9556463565f5041fc3b5b62afab104
https://doi.org/10.1182/blood-2010-11-320093
https://doi.org/10.1182/blood-2010-11-320093
Autor:
Borje S. Andersson, Marcos de Lima, Sergio Giralt, Daniel R. Couriel, Amin M. Alousi, Chitra Hosing, Rima M. Saliba, Cindy Ippoliti, Elizabeth J. Shpall, Richard E. Champlin, Issa F. Khouri
Publikováno v:
Biology of Blood and Marrow Transplantation. 15(12):1555-1562
Anti-Tumor Necrosis Factor Alpha (TNF-alpha) therapy with infliximab has shown to be effective for patients with steroid-refractory acute graft-versus-host disease (aGVHD). An open-labeled, phase III trial was conducted to determine if the addition o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19b4f7714df25dd1ec864f3e928a40f0
Autor:
K. Hicks, Joyce Neumann, Cindy Ippoliti, Issa F. Khouri, Yvonne Hsu, Borje S. Andersson, Rima M. Saliba, Maricer P. Escalon, Chitra Hosing, M. Donato, S. Ghosh, M. de Lima, Sergio Giralt, Richard E. Champlin, Daniel R. Couriel
Publikováno v:
British Journal of Haematology. 130:409-417
Chronic graft-versus-host disease (cGVHD) remains a major cause of morbidity and mortality in haematopoietic transplant recipients. Sirolimus is a macrocyclic triene antibiotic with immunosuppressive, antifungal and antitumour properties, that has ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b877efbcb1305fdc1e5c2caa23992cd0
https://doi.org/10.1111/j.1365-2141.2005.05616.x
https://doi.org/10.1111/j.1365-2141.2005.05616.x
Autor:
Daniel R. Couriel, Jeffrey J. Molldrem, Cindy Ippoliti, J. Alamo, Richard E. Champlin, Peter F. Thall, Raymond S.M. Wong, Borje S. Andersson, Xuemei Wang, Krishna V. Komanduri, Paolo Anderlini, Marcos de Lima, Sergio Giralt, Chitra Hosing, Munir Shahjahan, Elihu H. Estey, James Gajewski, M. Donato, Issa F. Khouri, Naoto T. Ueno
Publikováno v:
Biology of Blood and Marrow Transplantation. 11(2):108-114
Allogeneic progenitor cell transplantation is the only curative therapy for patients with refractory acute myelogenous leukemia or myelodysplastic syndromes. To identify prognostic factors in these patients, we performed a retrospective analysis of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e273cdd973adea939a3a544dcbdb51b4
Autor:
Marcos de Lima, Sergio Giralt, Borje S. Andersson, Richard E. Champlin, James Gajewski, Munir Shahjahan, Michele L. Donato, Jorge E. Cortes, Athanasios Anagnostopoulos, Mark F. Munsell, Daniel R. Couriel, Joyce Neumann, Cindy Ippoliti, Naoto T. Ueno
Publikováno v:
Blood. 104:865-872
Intensity of the preparative regimen is an important component of allogeneic transplantations for myelodysplasia (MDS) or acute myelogenous leukemia (AML). We compared outcomes after a truly nonablative regimen (120 mg/m2 fludarabine, 4 g/m2 cytarabi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::708ac5ccb414b244857974ce5fd87715
https://doi.org/10.1182/blood-2003-11-3750
https://doi.org/10.1182/blood-2003-11-3750